Manipulation of the tumor suppressor p53 for potentiating cancer therapy

Seminars in Cancer Biology
Susan Haupt, Ygal Haupt

Abstract

The tumor suppressor p53 is a linchpin in the regulation of appropriate cellular responses to various stress conditions. Inactivation of the functions of this critical participant can have diabolical consequences, in particular the development of malignant diseases. Elicitation of appropriate p53 functions is an attractive strategy for combating cancer. Triggering p53 responses, reconstituting p53 activities through gene therapy, coercing mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. Here, we will overview 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts.

References

Aug 21, 1992·Cell·B Vogelstein, K W Kinzler
Jul 2, 1992·Nature·D P Lane
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Oct 1, 1994·Current Biology : CB·T R Hupp, D P Lane
Oct 5, 1994·Journal of the National Cancer Institute·T FujiwaraJ A Roth
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M V BlagosklonnyL Neckers
Jul 15, 1996·The Biochemical Journal·K ShinoharaS Kawashima
May 16, 1997·The Journal of Biological Chemistry·U G LopesG M Cooper
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Jul 22, 1998·Nucleic Acids Research·J MomandJ Niland
Jan 5, 2000·Science·B A FosterF Rastinejad
Sep 1, 2000·Journal of Medicinal Chemistry·C García-EcheverríaP Furet
Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Assaf FriedlerAlan R Fersht
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
Mar 20, 2002·Nature Reviews. Cancer·A N Bullock, A R Fersht
Apr 3, 2002·Trends in Molecular Medicine·Len Neckers
Apr 12, 2002·Oncogene·Thomas M RippinAlan R Fersht
Jul 10, 2002·The Journal of Peptide Research : Official Journal of the American Peptide Society·Raja BanerjeeSiddhartha Roy
Oct 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Young R SeoMartin L Smith
Nov 2, 2002·Nature Medicine·Andrei V Gudkov
Feb 4, 2003·Nature Reviews. Cancer·Patrick Chène
Feb 4, 2003·Nature Reviews. Cancer·Andrei V Gudkov, Elena A Komarova
Mar 15, 2003·The Journal of Biological Chemistry·Elena A KomarovaAndrei V Gudkov
Mar 26, 2003·Seminars in Cancer Biology·Irina V LebedevaPaul B Fisher
Apr 12, 2003·Drug Discovery Today·David P Lane, Ted R Hupp
Apr 18, 2003·The Journal of Biological Chemistry·Assaf FriedlerAlan R Fersht

❮ Previous
Next ❯

Citations

Apr 24, 2014·Apoptosis : an International Journal on Programmed Cell Death·Xin YuDarren R Carpizo
Dec 15, 2012·Apoptosis : an International Journal on Programmed Cell Death·Claudia FioriniMassimo Donadelli
Aug 16, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Changqing SuQijun Qian
Aug 25, 2010·Pharmaceutical Biology·Wen-Zong LuZeng-Sheng Han
Oct 26, 2005·Growth Factors·Yaara Levav-CohenYgal Haupt
May 4, 2010·Seminars in Cancer Biology·Mark Shackleton
Mar 9, 2010·Seminars in Cancer Biology·Alice Machado-SilvaJean-Christophe Bourdon
Mar 2, 2012·The Journal of Investigative Dermatology·Valentina ManféRobert Gniadecki
May 4, 2005·Biochemical and Biophysical Research Communications·Yaara Levav-CohenYgal Haupt
Jul 31, 2007·Biochemical and Biophysical Research Communications·Lavinia NardinocchiGabriella D'Orazi
Jul 21, 2005·Technology in Cancer Research & Treatment·T RobsonD G Hirst
Jan 26, 2007·Nature·Andrea VenturaTyler Jacks
Aug 24, 2006·Anti-cancer Drugs·Sue Haupt, Ygal Haupt
Mar 23, 2010·Journal of Biomolecular NMR·Christian HerbstRamadurai Ramachandran
Feb 14, 2006·Oncogene·L BarazI Vlodavsky
Jun 15, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Zhuo ZhangHui Wang
Jun 16, 2012·Biomechanics and Modeling in Mechanobiology·Sandra Klinge
Sep 1, 2012·Journal of the Science of Food and Agriculture·Renata H B FuchsMakoto Matsushita
Feb 12, 2014·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·Jean-Paul V Pelteret, Batmanathan D Reddy
Oct 13, 2006·World Journal of Gastroenterology : WJG·Ruben Hernandez-AlcocebaJesus Prieto
Apr 6, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Xinkui LiuXiaomeng Zhang
May 26, 2020·BMC Complementary Medicine and Therapies·Zeina W Sharawi
Feb 18, 2020·Recent Patents on Food, Nutrition & Agriculture·Ingy M El-HefnyWesam T Basal

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis